Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
514497
Reference Type
Journal Article
Title
Pharmacokinetics of diclofenac in rats intoxicated with CCL4, and in the regenerating liver
Author(s)
Reyes-Gordillo, K; Muriel, P; Castaneda-Hemandez, G; Favari, L
Year
2007
Is Peer Reviewed?
Yes
Journal
Biopharmaceutics and Drug Disposition
ISSN:
0142-2782
EISSN:
1099-081X
Volume
28
Issue
8
Page Numbers
415-422
Language
English
DOI
10.1002/bdd.569
Abstract
The pharmacokinetics of an intravenous and oral diclofenac dose of 3.2mg/kg was studied in male Wistar rats under control conditions, 1 and 3 days after liver damage and regeneration induced by an oral injection of CCI4. One day after CCI4 administration, indicators of necrosis (alanine aminotransferase), cholestasis (gamma-glutamyl transpeptidase) and regeneration (a-fetoprotein) were significantly increased; these effects were reversed after 3 days. In nonintoxicated rats, t(1/2) was 43.83 +/- 4.95 min, V-d was 0.37 +/- 0.041/kg, Cl was 129.21 +/- 9.20ml/min kg, AUC(i.v.) was 25.62 +/- 1.45 mu g/min ml, and AUC(p.o.) was 20.21 +/- 1.03. One day after intoxication, when the liver was damaged and regenerating, the metabolism was decreased: diclofenac t1/2 was increased to 258.21 +/- 30.80 min but Vd did not change significantly, therefore Cl was reduced to 32.81 +/- 3.38 ml/min kg. By day 3 after intoxication, liver function, regeneration and pharmacokinetics returned to normal. The results show that liver damage and regeneration increases the bioavailability by decreasing elimination. The present observations suggest that reduction of the pharmacokinetic parameters may lead to drug accumulation in the regenerating-damaged liver with an attendant possible increase in toxic effects. The results in rats, also suggest that once hepatic injury is finished and regeneration is complete, diclofenac can be administered normally. Copyright (0 2007 John Wiley & Sons, Ltd.
Keywords
diclofenac; liver injury; liver regeneration; carbon tetrachloride; necrosis; pharmacokinetics; clinical pharmacokinetics; carbon-tetrachloride; hepatic regeneration; alpha-fetoprotein; disease; sodium; bioavailability; binding; update; injury
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity